close

Enter

Log in using OpenID

Cell and Gene Therapy Market

embed
Cell and Gene Therapy Market - Size, Share,
Growth, Outlook, and Opportunity Analysis,
2018-2026
Cell therapy is the administration of living cells in patients for the treatment of a disease. The source
of cell can be autologous or allogeneic, which can be derived from stem cells such as bone marrow.
Stem cells therapy is used in bone marrow transplantation. Gene therapy is the introduction, removal,
or change in the patient's genetic code for treatment of a disease. Moreover, it modifies the
expression of an individual’s genes or repair abnormal genes. The therapy involves administration of
nucleic acid (DNA/RNA) with carriers called as vectors.
Request Sample Copy of Research Report:
https://www.coherentmarketinsights.com/insight/request-sample/2475
Cell and gene therapy plays a major role in modern healthcare, as they provide concepts and
techniques that can be used in gene regulation, cell-cell interactions, regenerative capacity, and
remodeling.
The global cell and gene therapy market size was valued at US$ 6,020.0 million in 2017 and is
expected to exhibit a CAGR of 21.9% over the forecast period (2018 – 2026).
Increasing prevalence of cardiovascular disease and cancer is expected to propel
growth of cell and gene therapy market
Gene therapy aims at influencing the course of various genetic and acquired disorders at the
genetic level whereas cell therapy targets various diseases at the cellular level i.e. by restoration
of a certain cell population or using cells as carriers of therapeutic carrier. High prevalence of
cardiovascular disease is expected to propel demand for cell and gene therapy, which in turn is
expected to drive the market growth. According to the World Health Organization (WHO), May
2017, around 17.9 million people died due to cardiovascular disease in 2016 globally, which
accounts for 31% of all worldwide deaths. According to WHO, in 2012, cancer was the second
leading cause of morbidity and mortality globally, with around 14 million new cases registered in
2012 and in 2015, cancer was responsible for 8.8 million deaths, worldwide. Moreover, WHO
stated that the number of new cases is expected to rise by around 70% by 2030.
Report includes chapters which deeply display the following deliverable about industry :
• Cell and Gene Therapy Market Research Objective and Assumption
• Cell and Gene Therapy Market Purview - Report Description, Executive Summary, and Coherent
Opportunity Map (COM)
• Cell and Gene Therapy Market Dynamics, Regulations, and Trends Analysis - Market Dynamics,
Regulatory Scenario, Industry Trend, Merger and Acquisitions, New system Launch/Approvals, Value
Chain Analysis, Porter’s Analysis, and PEST Analysis
• Global Cell and Gene Therapy Market, By Regions
• Cell and Gene Therapy Market Competition by Manufacturers including Production, Share,
Revenue, Average Price, Manufacturing Base Distribution, Sales Area and Product Type.
• Cell and Gene Therapy Market Manufacturers Profiles/Analysis including Company Basic
Information, Manufacturing Base and Its Competitors.
• Cell and Gene Therapy Market Manufacturing Cost Analysis including Key Raw Materials and Key
Suppliers of Raw Materials.
• Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials
Sourcing and Downstream Buyers
• Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market Positioning
and Distributors/Traders List.
• Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer
Preference Change and Economic/Political Environmental Change.
• Cell and Gene Therapy Market Forecast including Production, Consumption, Import and Export
Forecast by Type, Applications and Region.
• Research Findings and Conclusion
Key Players
Major players operating in the global cell and gene therapy market include Amgen,
Biogen, BioMarin Pharmaceuticals, Bristol-Myers Squibb Company, GlaxoSmithKline,
Novartis, Pfizer, Regeneron Pharmaceuticals and Sanofi, Spark Therapeutics, Agilis
Biotherapeutics, Angionetics AVROBIO, Freeline Therapeutics, Horama, MeiraGTx,
Myonexus Therapeutics, Nightstar Therapeutics, Kolon TissueGene, Inc., JCR
Pharmaceuticals Co., Ltd., and MEDIPOST.
Inquire Here Before Purchase:
https://www.coherentmarketinsights.com/insight/talk-to-analyst/2475
Detailed Segmentation:
• Global Cell and Gene Therapy
• Cell Therapy
• Stem Cells
• T Cells
• Dendritic Cells
• NK Cells
• Tumor Cells
• Gene Therapy
• Global Cell and Gene Therapy
• Cardiovascular Disease
• Cancer
• Genetic Disorder
• Infectious Disease
• Neurological Disorders
• Others
• Global Cell and Gene Therapy
• In House
• Outsourced
• Global Cell and Gene Therapy
• North America
Market, By Therapy Type:
Market, By Indication:
Market, By Scale of Operation:
Market, By Geography:
About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering action-ready
syndicated research reports, custom market analysis, consulting services, and competitive analysis
through various recommendations related to emerging market trends, technologies, and potential
absolute dollar opportunity.
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: [email protected]
Author
Rushikesh
Rushikesh52   documents Email
Document
Category
Health and Medicine
Views
1
File Size
168 KB
Tags
gene
1/--pages
Report inappropriate content